Search research articles
Contact Us
Filters
Showing results (101-110 of 167) with videos related to
Page
of 17
Sort By:
Nature Communications
|
October 28, 2025
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling
Anish Thomas, Nobuyuki Takahashi, Lenka Oplustil O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2019
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma
Christine Alewine, Mehwish Ahmad, Cody J Peer, et al.
Nature Cancer
|
November 21, 2022
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Yoko Nishiga, Alexandros P Drainas, Maya Baron, et al.
Molecular Cancer Therapeutics
|
August 24, 2022
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors
Anish Thomas, Shaun D Fontaine, Morgan E Diolaiti, et al.
Biorxiv : the Preprint Server for Biology
|
December 8, 2025
Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition
Hyerim Jung, Yoonji Lee, Donghoon Yu, et al.
JAMA Network Open
|
February 27, 2020
Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
Ananta Subedi, Sandra G Williams, Lawrence Yao, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Molecular Cancer Therapeutics
|
May 2, 2026
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer
Azam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2018
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Luciano Mutti, Tobias Peikert, Bruce W S Robinson, et al.
Life (Basel, Switzerland)
|
August 29, 2024
Predictors of Outcomes and a Weighted Mortality Score for Moderate to Severe Subdural Hematoma
Sima Vazquez, Aarti K Jain, Bridget Nolan, et al.
Page
of 17
Search research articles
Search
Showing results (101-110 of 167) with videos related to
Sort By:
Page
of 17
Nature Communications
|
October 28, 2025
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling
Anish Thomas, Nobuyuki Takahashi, Lenka Oplustil O'Connor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2019
Phase I/II Study of the Mesothelin-targeted Immunotoxin LMB-100 with Nab-Paclitaxel for Patients with Advanced Pancreatic Adenocarcinoma
Christine Alewine, Mehwish Ahmad, Cody J Peer, et al.
Nature Cancer
|
November 21, 2022
Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect
Yoko Nishiga, Alexandros P Drainas, Maya Baron, et al.
Molecular Cancer Therapeutics
|
August 24, 2022
PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM-Deficient Tumors and Potent Synergy With PARP Inhibitors
Anish Thomas, Shaun D Fontaine, Morgan E Diolaiti, et al.
Biorxiv : the Preprint Server for Biology
|
December 8, 2025
Sensitizing tumor response to topoisomerase I antibody drug conjugate by selective CDK7 inhibition
Hyerim Jung, Yoonji Lee, Donghoon Yu, et al.
JAMA Network Open
|
February 27, 2020
Use of Magnetic Resonance Imaging to Identify Immune Checkpoint Inhibitor-Induced Inflammatory Arthritis
Ananta Subedi, Sandra G Williams, Lawrence Yao, et al.
Biorxiv : the Preprint Server for Biology
|
October 1, 2025
SMARCA4 is essential for early-stage tumor development but its loss promotes late-stage cancer progression in small-cell lung cancer
Nicole A Kirk, Jin Ng, Kate-Lin Ly, et al.
Molecular Cancer Therapeutics
|
May 2, 2026
HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer
Azam Ghafoor, Linying Zhu, Zoe Weaver Ohler, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 4, 2018
Scientific Advances and New Frontiers in Mesothelioma Therapeutics
Luciano Mutti, Tobias Peikert, Bruce W S Robinson, et al.
Life (Basel, Switzerland)
|
August 29, 2024
Predictors of Outcomes and a Weighted Mortality Score for Moderate to Severe Subdural Hematoma
Sima Vazquez, Aarti K Jain, Bridget Nolan, et al.
Page
of 17